Targeted Drug Delivery Strategies for Infectious Diseases

Dear Colleagues,

Infectious diseases that can be transmitted, either directly or indirectly, from one person to another through pathogenic microorganisms, such as bacteria, viruses, parasites, or fungi, are long-standing threats to human society. These diseases lead to high mortality rates, disrupt health systems, and negatively impact the economy, particularly in middle- and low-income countries. The emergence of new diseases, such as COVID-19 in 2020, the rise in antimicrobial resistance, and the persistence of longstanding diseases like leishmaniasis, tuberculosis, and Chagas disease present formidable challenges and demand effective public health strategies. The development of new treatment options is essential, focusing on therapies that are highly effective, less toxic, and affordable. In this context, a promising approach is the development of drug-specific delivery systems that target the desired site of action, utilizing recent advances in biomaterials, including liposomes, dendrimers, nanotubes, nanoshells, and others.

This Special Issue will provide readers with an overview of the current advances in targeted drug delivery strategies for infectious diseases. Research articles and comprehensive reviews are welcome.

Dr. Danielle Lazarin Bidóia
Dr. Daniele Stéfanie Sara Lopes Lera-Nonose
Dr. Áquila Carolina Fernandes Herculano Ramos Milaré
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.